FDA Panel OKs Low-Dose Pfizer COVID Vaccine for Children 5 and Up

FDA Panel OKs Low-Dose Pfizer COVID Vaccine for Children 5 and Up

A Food and Drug Administration advisory has approved the use of low-dose Pfizer's COVID vaccine for children 5- to 11-year-olds.
Pfizer’s COVID Vaccine Shows Low Dose Are Safe, Effective for Children 5 to 11

Pfizer's COVID Vaccine Shows Low Dose Are Safe, Effective for Children 5 to 11

Vaccine maker Pfizer with its partner BioNTech said that its COVID vaccine is safe and effective for children ages five to 11 at low doses, particularly one-third of the dose used in adolescents and adults.
Real Time Analytics